To the best of our knowledge, the present study is the only work assessing the subcellular expression of ERα, ERβ1, ERβ2 and ERβ5 in a well-validated cohort of different histotypes of ovarian cancers with complete follow-up data, using specific well-validated antibodies. The gene discussed is ESR1; the disease is ovarian carcinoma.